glp 1 reimbursement Employers Grapple with Claims Costs versus Outcomes of GLP-1 Drugs The Health and Healthcare Spending

[DOI] [PubMed] [Google Scholar] 196.Wai K.M., Mishra K., Koo E., Ludwig C.A., Parikh R., Mruthyunjaya P., Rahimy E

Documentation must include: Medical necessity (e.g., failed conservative therapy, functional limitation) Muscles treated Medications used (e.g., lidocaine, bupivacaine, corticosteroids) Response to prior treatment , if applicable Coding Tips Do not report CPT 20552 in conjunction with dry needling (CPT 20560 or 20561) unless both are distinct and separately identifiable procedures

Though this dose is smaller (50 mg vs 250 mg), this quick intramuscular shot delivers lasting energy, mental clarity, and cellular support

SURMOUNT-1 reported up to 22.5% body weight loss at the 15 mg tirzepatide dose [2]

2004 Jul;11 Suppl 1:S73-85

Patel M, Loree JM, Taggart MW, Malpica A, Matamoros A, Kopetz S , Varadhachary GR, Fournier KF, Royal RE, Raghav KPS